B-cell Maturation Antigen (BCMA) Targeted Therapies Market Development Analysis Contributing Top Vendor Landscape and Economic Growth 2028
BCMA is a member of tumor necrosis factor family and has critical role in the regulating B-cell proliferation and survival. The interaction of BCMA with its ligand has also shown to promote the progression of cancer. Further, studies have also demonstrated that BCMA is central to the survival of multiple myeloma cells. Therefore, researchers have adopted several approaches to target this antigen as an alternative for the management of multiple myeloma. Drivers: Increasing number of recurring cases of MM across the world is expected to augment growth of the global B-cell maturationAntigen (BCMA) targeted therapies market during the forecast period. Patients undergoing radiation therapy and chemotherapy are at higher risk of cancer recurrence because they develop resistance to these therapy. At this time, there is no cure for recurrent cancer and therefore BCMA targeted therapies provide successful therapeutic options for the treatment of recurrent MM. Increasing ...